Processa Pharmaceuticals PCSA
NASDAQ PCSA
$1.55 -0.07 (-4.32%)
At close: Oct 2, 2026 · 4:00 PM EDT

Processa Pharmaceuticals (PCSA) Non Operating Investment Income (2015)

Updated

Processa Pharmaceuticals (PCSA) posted Non Operating Investment Income of -$25,000 for FY2016, compared with -$60,743 in FY2015.

Analysis

Processa Pharmaceuticals (PCSA) Non Operating Investment Income (2015) Analysis & Trends

  • Business Quant data shows PCSA's Non Operating Investment Income at -$60,743 in FY2015.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Op. Investment Inc. (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn -
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn -
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn -
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn -
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn -
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn -
10 Processa Pharmaceuticals 4.33 Mn 4.33 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2015 -13,682.00
Sep 30, 2015 -43,308.00
Jun 30, 2015 -3,753.00
API Access

Processa Pharmaceuticals Non Operating Investment Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-investment-income&ticker=PCSA&period=max&api_key=YOUR_API_KEY